ACALABRUTINIB AND THE POSSIBILITIES OF THERAPY OF CHRONIC LYMPHOCYTIC LEUKEMIA IN SUBSEQUENT LINES IN A COMORBID PATIENT. CLINICAL OBSERVATION
K.V. Menshikov1,2, A.V. Sultanbaev1, Sh.I. Musin1, I.A. Menshikova2, V.S. Chalov3, N.I. Sultanbaeva1, A.Sh. Rezyapova2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa 3Center of PET Technology, Center of nuclear Medicine, Ufa Sultanbaev Aleksandr V. ― Cand. of Sci. (Med.), Head of the Department of Antitumor Drug Therapy of the Republican Clinical Oncology Dispensary … Читать далее